Our client is an early-stage biotechnology company developing first-in-class small molecule inhibitors to treat metabolic diseases. With funding and support from venture capital, and an expert core team, they are dedicated to advancing development of their therapeutic candidates and delivering effective treatments for diseases associated with obesity and type-2 diabetes. […]
Our client is seeking an experienced professional who can drive the development and execution of a strategy for their preclinical research program. Working closely with the CSO and founder, you will:
Form a preclinical development...